Moffitt Cancer Center Researchers Discover Mechanism Leading to BRAF Inhibitor Resistance in Melanoma Patients

Moffitt Cancer Center Researchers Discover Mechanism Leading to BRAF Inhibitor Resistance in Melanoma Patients

Moffitt Cancer Center Researchers Discover Mechanism Leading to BRAF Inhibitor Resistance in Melanoma Patients

TAMPA, Fla. – The development of targeted therapies has significantly improved the survival of melanoma patients over the last decade; however, patients often relapse because many therapies do not kill all of the tumor cells, and the remaining cells adapt to treatment and become resistant. Moffitt Cancer Center researchers have discovered a novel mechanism that can lead melanoma cells to develop resistance to drugs that target the protein BRAF.

Related posts

UNF physics lecturer receives U.S. Patent

Nirmalkumar Patel, a University of North Florida physics associate lecturer, received a U.S. Patent for…

UNF professor reports on returning to exercise post-pandemic, staying healthy in the new year

Dr. James Churilla, UNF professor and Exercise Science and Chronic Disease Graduate Program director, recently…

FIT Biochemist Studies Farming on Mars

Farming on Mars will be a lot harder than ‘The Martian’ made it seem.  Growing…